NLTX Annual Total Assets
$115.95 M
-$47.31 M-28.98%
31 December 2022
Summary:
As of February 5, 2025, NLTX annual total assets is $115.95 million, with the most recent change of -$47.31 million (-28.98%) on December 31, 2022. During the last 3 years, it has fallen by -$31.07 million (-21.14%).NLTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Quarterly Total Assets
$89.59 M
-$4.42 M-4.70%
30 September 2023
Summary:
As of February 5, 2025, NLTX quarterly total assets is $89.59 million, with the most recent change of -$4.42 million (-4.70%) on September 30, 2023. Over the past year, it has dropped by -$36.99 million (-29.22%).NLTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLTX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.0% | -29.2% |
| 3 y3 years | -21.1% | -59.6% |
| 5 y5 years | +5.1% | +2.0% |
NLTX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -44.9% | -59.6% |
Neoleukin Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $89.59 M(-4.7%) |
| June 2023 | - | $94.00 M(-4.5%) |
| Mar 2023 | - | $98.46 M(-15.1%) |
| Dec 2022 | $115.95 M(-29.0%) | $115.95 M(-8.4%) |
| Sept 2022 | - | $126.58 M(-7.6%) |
| June 2022 | - | $137.02 M(-8.1%) |
| Mar 2022 | - | $149.13 M(-8.7%) |
| Dec 2021 | $163.26 M(-22.4%) | $163.26 M(-7.2%) |
| Sept 2021 | - | $175.93 M(-5.9%) |
| June 2021 | - | $187.02 M(-6.5%) |
| Mar 2021 | - | $200.10 M(-4.9%) |
| Dec 2020 | $210.52 M(+43.2%) | $210.52 M(-5.0%) |
| Sept 2020 | - | $221.69 M(+52.5%) |
| June 2020 | - | $145.32 M(-5.0%) |
| Mar 2020 | - | $153.05 M(+4.1%) |
| Dec 2019 | $147.02 M(+89.4%) | $147.02 M(+110.7%) |
| Sept 2019 | - | $69.79 M(-5.4%) |
| June 2019 | - | $73.74 M(-2.2%) |
| Mar 2019 | - | $75.43 M(-2.8%) |
| Dec 2018 | $77.62 M | $77.62 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $87.81 M(-15.9%) |
| June 2018 | - | $104.43 M(+9.2%) |
| Mar 2018 | - | $95.62 M(-13.3%) |
| Dec 2017 | $110.33 M(-28.5%) | $110.33 M(-9.3%) |
| Sept 2017 | - | $121.60 M(-8.8%) |
| June 2017 | - | $133.28 M(-7.0%) |
| Mar 2017 | - | $143.33 M(-7.2%) |
| Dec 2016 | $154.38 M(+36.2%) | $154.38 M(-5.9%) |
| Sept 2016 | - | $164.07 M(+62.9%) |
| June 2016 | - | $100.70 M(-6.9%) |
| Mar 2016 | - | $108.21 M(-4.5%) |
| Dec 2015 | $113.34 M(+173.6%) | $113.34 M(-4.0%) |
| Sept 2015 | - | $118.03 M(+295.3%) |
| June 2015 | - | $29.86 M(-15.0%) |
| Mar 2015 | - | $35.13 M(-15.2%) |
| Dec 2014 | $41.42 M(+164.7%) | $41.42 M(-14.8%) |
| Sept 2014 | - | $48.62 M(-8.2%) |
| June 2014 | - | $52.96 M(-6.2%) |
| Mar 2014 | - | $56.45 M(+260.7%) |
| Dec 2013 | $15.65 M(+568.2%) | $15.65 M |
| Dec 2012 | $2.34 M | - |
FAQ
- What is Neoleukin Therapeutics annual total assets?
- What is the all time high annual total assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics annual total assets year-on-year change?
- What is Neoleukin Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Neoleukin Therapeutics?
- What is Neoleukin Therapeutics quarterly total assets year-on-year change?
What is Neoleukin Therapeutics annual total assets?
The current annual total assets of NLTX is $115.95 M
What is the all time high annual total assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high annual total assets is $210.52 M
What is Neoleukin Therapeutics annual total assets year-on-year change?
Over the past year, NLTX annual total assets has changed by -$47.31 M (-28.98%)
What is Neoleukin Therapeutics quarterly total assets?
The current quarterly total assets of NLTX is $89.59 M
What is the all time high quarterly total assets for Neoleukin Therapeutics?
Neoleukin Therapeutics all-time high quarterly total assets is $221.69 M
What is Neoleukin Therapeutics quarterly total assets year-on-year change?
Over the past year, NLTX quarterly total assets has changed by -$36.99 M (-29.22%)